just my opinion, developing pipeline is risky, it’s all essentially the same stuff, if any one trial goes bad could devalue the whole lot, and CBD is too political still, policy changing to give FDA more control over it as a medical product, but to me pipeline is as advanced as BOT need it to be right now.
They said they want to grow it, so I think they’ll either licence or launch SB, use money to buy another thing, launch it, buy another thing. If that’s their thinking, I don’t see them selling for less than $2-3 per share.
- Forums
- ASX - By Stock
- BOT
- Bot Chart
Bot Chart, page-10572
-
- There are more pages in this discussion • 3,735 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $628.9M |
Open | High | Low | Value | Volume |
35.0¢ | 35.5¢ | 34.5¢ | $688.2K | 1.972M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 460433 | 35.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.5¢ | 293106 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 444845 | 0.350 |
6 | 261079 | 0.345 |
21 | 320463 | 0.340 |
12 | 148105 | 0.335 |
18 | 461271 | 0.330 |
Price($) | Vol. | No. |
---|---|---|
0.355 | 304918 | 9 |
0.360 | 432592 | 14 |
0.365 | 287997 | 12 |
0.370 | 384038 | 12 |
0.375 | 476689 | 10 |
Last trade - 11.48am 28/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
Previous Video
Next Video
SPONSORED BY The Market Online